Skip to main content
Clinical Trials/ITMCTR2000003911
ITMCTR2000003911RecruitingPhase 1

Study on the clinical effect and mechanism of Jianpi Jieyu Decoction on depressive episode

Zhejiang Tongde hospital0 sitesStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
18 to 65 (—)
Sex
All

Inclusion Criteria

  • 1. Patients who meet the diagnostic criteria of DSM - V for depressive episode;
  • 2. Hamilton Rating Scale for depression (HAMD) score of 24 items = 21;
  • 3. Patients aged 18-65 years, regardless of gender, educational level, occupation, economic status, etc;
  • 4. The patient was unconscious and could understand the content of the scale and cooperate with the treatment.

Exclusion Criteria

  • 1. Patients with serious suicidal tendency;
  • 2. Patients with bipolar disorder, schizophrenia and other mental diseases, or depression secondary to other mental diseases or physical diseases;
  • 3. The patients with serious heart, liver, kidney, blood, rheumatism, tumor, malnutrition and nervous system degeneration have brain organic diseases, and have a history of abuse of alcohol, tobacco and other psychoactive substances;
  • 4. Patients who use any other antipsychotics, other antidepressants, mood stabilizers, anti anxiety drugs, central stimulants, immunomodulators, immunosuppressants and hormones during the study period; use systemic psychotherapy; use physical therapy such as MECT; and;
  • 5. Patients with drug allergy or contraindications or previous ineffective use of such drugs;
  • 6. Pregnant women;
  • 7. Patients without informed consent.

Investigators

Sponsor
Zhejiang Tongde hospital

Similar Trials

Study on the clinical effect and mechanism... | Clinical Trial